Gary A. Curtis

Concentric Medical, Inc. designs, manufactures and distributes medical devices. The company was founded in August 1999 and is headquartered in Kalamazoo, MI.

Part of Boston Scientific Corp., RadioTherapeutics Corp is a company that develops and manufactures proprietary radiofrequency-based therapeutic devices in the field of interventional oncology. The company is based in Sunnyvale, CA. RadioTherapeutics was acquired by Boston Scientific Corp. on November 08, 2001.

Fusion Medical Technologies, Inc. is used to develop, manufactures and market surgical hemostatic products like sutures and topical agents such as sponges which are used to stop bleeding in a variety of surgeries. The Company's product floSeal (R) matrix hemostatic sealant was used to control surgical bleeding. It products were used in a variety of surgical procedures like cardiac, vascular, spinal, ear, nose, throat, head, neck and cranial surgeries. The company marketed its products through direct sales force. It was headquartered in Fremont, CA.

Biometric Imaging, Inc. manufactures cellular analysis instruments. It offers services to clinics, hospitals, blood banks, and cancer management centers for disease management and therapy monitoring. The company was founded by Bala S. Manian in 1992 and is headquartered in Mountain View, CA.

Percutaneous Systems, Inc. designs, develops, and commercializes medical devices. Its PercSys Accordion Stone Management Device and the Accordion CoAx Stone Control Devices are designed to simplify and shorten endoscopic lithotripsy procedures by combining the utility of multiple endoscopic stone management tools into a single device. The company was founded by Robert Behl in 2003 and is headquartered in Palo Alto, CA.

Invuity, Inc. operates as a medical technology company. The firm engages in the development and marketing of surgical and medical devices. Its products include retractors, handhelds and drop-ins under the Photonics and PhotonBlade brands. The company was founded by Kenneth B. Trauner and Alex Vayser on November 29, 2004 and is headquartered in San Francisco, CA.

SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ